This study evaluated the effectiveness and safety of Jinhua Qinggan Granule (JHG) in treating influenza patients suffering from wind-heat affecting the lungs (WHAFS).
A total of 136 patients were split into three groups: a high dose JHG group, a low dose JHG group, and a placebo control group, with treatments administered three times daily for five days.
Results indicated that the low dose JHG group had a faster fever disappearance time and higher recovery rates compared to the placebo, while safety was comparable across all groups.